Wednesday, April 29, 2015 8:20:58 AM
APR 28, 2015 Markets Staff
On a consensus basis, Street analysts are expecting Rockwell Medical, Inc. (NASDAQ:RMTI) to report earnings per share of $-0.1 for the quarter ending 2015-03-31. The company is next slated to report quarterly earnings on or around 2015-05-11. Rockwell Medical, Inc. (NASDAQ:RMTI) last reported quarterly EPS of $-0.14 for the quarter ended 2014-12-31 on 2015–0-2-26. This number was $-0.08 away from what analysts were expecting, resulting in a surprise factor of -133.33%.
There are 5 covering research analysts that have issued an anticipated price level where they predict the stock will reach within the next year. The consensus target for these analysts sits at $16 for Rockwell Medical, Inc.. The highest analyst target sees the stock at $26 within the year. The lowest analyst target sees the stock at $4 over the same time period.
Wall Street analysts have a mean estimate for long-term growth of $25 on the stock. When looking at the three months ago number, they had a long-term growth mean estimate of $25 on the company.
Placing analyst ratings on a recommendation scale, Rockwell Medical, Inc. has a mean rating of 1.8. Using this scale, a one would represent a Strong Buy recommendation and a five would represent a Strong Sell recommendation. There are 5 broker recommendations that this rating is based on.
Profile
Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient’s bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.
From http://www.themarketsdaily.com/brokerage-firm-focus-rockwell-medical-inc-nasdaqrmti/13267/
Recent RMTI News
- Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States • Business Wire • 04/17/2024 10:00:00 AM
- Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024 • Business Wire • 04/16/2024 10:00:00 AM
- Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda • Business Wire • 04/04/2024 10:00:00 AM
- Rockwell Medical Named 'Great Place to Work' for Second Year in a Row • Business Wire • 03/25/2024 10:00:00 AM
- Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 • Business Wire • 03/21/2024 10:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:31:02 PM
- Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024 • Business Wire • 02/08/2024 11:00:00 AM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:56:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:36:07 PM
- Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund • Business Wire • 01/08/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 11:52:15 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 11:15:54 AM
- Rockwell Medical Announces Third Quarter 2023 Results • Business Wire • 11/14/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:18:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:17:25 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:16:39 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/18/2023 10:16:02 AM
- Rockwell Medical Names Jesse Neri as Senior Vice President, Finance • Business Wire • 10/18/2023 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 10:15:59 AM
- Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors • Business Wire • 10/17/2023 10:00:00 AM
- Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023 • Business Wire • 10/16/2023 10:00:00 AM
- Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care • Business Wire • 10/03/2023 10:00:00 AM
- Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah • Business Wire • 09/28/2023 10:00:00 AM
- Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024 • Business Wire • 09/21/2023 10:30:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM